PIPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Piper Sandler Companies (PIPR) is a good buy for a beginner investor with a long-term horizon and $50,000-$100,000 to invest. The company's strong financial performance, recent strategic appointments in healthcare investment banking, and growth in revenue and net income make it a compelling investment opportunity despite neutral technical indicators and mixed analyst ratings.
The MACD histogram is -2.512, below 0, and negatively contracting, indicating bearish momentum. RSI_6 is at 41.183, which is neutral. Moving averages are converging, suggesting no clear trend. Key support is at 305.47, and resistance is at 340.293. The stock is currently trading pre-market at $314, slightly below the pivot level of 322.881.
Strong Q4 2025 financial performance with revenue up 37.90% YoY, net income up 65.03% YoY, and EPS up 65.80% YoY.
Strategic appointments in healthcare investment banking to enhance competitive edge and client relationships.
Wolfe Research raised the price target to $398 with an Outperform rating, highlighting strong prospects in the retail brokers and alternative managers subsectors.
BofA maintains an Underperform rating, citing limited potential for outsized EPS growth compared to peers.
Neutral trading sentiment from hedge funds and insiders.
Pre-market price is down 0.80%, reflecting slight bearish sentiment.
In Q4 2025, Piper Sandler reported a 37.90% YoY increase in revenue to $662.04M, a 65.03% YoY increase in net income to $113.97M, and a 65.80% YoY increase in EPS to $6.4. Gross margin improved slightly to 99.86%.
Mixed analyst ratings. Wolfe Research raised the price target to $398 with an Outperform rating, while BofA maintains an Underperform rating with a price target of $395, citing limited EPS growth potential compared to peers.
